www.bioss.com.cn
400-901-9800
sales@bioss.com.cn
techsupport@bioss.com.cn
SARS-CoV-2(2019-nCoV) Nucleocapsid protein (S235F) Mutated Peptide
Product Name:
SARS-CoV-2(2019-nCoV) Nucleocapsid protein (S235F) Mutated Peptide
Cat. Number:
bs-24822P
Quantity size:
500ug
Source:
Synthetic Peptide
Form:
lyophilized powde
Purity:
≥95% (Purified by HPLC)
Storage:
 Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles.
Application:
Immunology research
Background:
Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus nucleoproteins localize to the cytoplasm and the nucleolus, a subnuclear structure, in both virus-infected primary cells and in cells transfected with plasmids that express N protein. Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. During virion assembly, N protein binds to viral RNA and leads to formation of the helical nucleocapsid. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.
Also known as:
SARS-CoV-2 Nucleocapsid Protein; SARS-CoV-2 NP; nucleocapsid protein [Severe acute respiratory syndrome coronavirus 2]; novel coronavirus N Protein; novel coronavirus Nucleocapsid Protein; 2019-nCoV Nucleoprotein; 2019-nCoV N; 2019nCoV N; 2019-nCoV N Protein; 2019 ncov N Protein; 2019-nCoV nucleocapsid protein, 2019-nCOV Nucleocapsid protein (S235F).
Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.